Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1983 Jul;41(1):97–105. doi: 10.1128/iai.41.1.97-105.1983

Immune serum-mediated effects on brucellosis evolution in mice.

M Plommet, A M Plommet
PMCID: PMC264748  PMID: 6408007

Abstract

Immune serum injected into mice before a footpad challenge of virulent strain Brucella abortus 544 can prevent dissemination of infection to the spleen. Sera from mice infected with Brucella for at least 2 months or from mice vaccinated with a protein-bound cell wall peptidoglycan Brucella fraction completely stopped dissemination. Brucella lipopolysaccharide and polysaccharide cross-reacting Yersinia immune sera reduced dissemination. Both peptidoglycan and lipopolysaccharide immune sera injected simultaneously with an intravenous challenge caused a shift in Brucella from spleen to liver. When immune sera were injected simultaneously with an intravenous challenge, the kinetics of splenic infection showed two effects: an early one, optimally measured at day 7 postchallenge, showed reduced numbers in the spleen due to the shift of Brucella to the liver; a late effect, measured at day 21 postchallenge, showed reduced numbers in spleen and liver with nearly complete clearance by day 49 postchallenge. Brucella lipopolysaccharide and cross-reacting bacterial antisera induced the early effect only, whereas peptidoglycan and infected mouse sera induced both effects. When peptidoglycan immune serum was injected 2 or 7 days after intravenous challenge, the late effect was somewhat reduced. Hence, immune sera to protein and polysaccharide surface antigens can (i) prevent dissemination of systemic infection and (ii) help destroy intercellular bacteria (protein antigen only). These effects may represent a large part of vaccinal immunity.

Full text

PDF
97

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ahvonen P., Jansson E., Aho K. Marked cross-agglutination between Brucellae and a subtype of Yersinia enterocolitica. Acta Pathol Microbiol Scand. 1969;75(2):291–295. [PubMed] [Google Scholar]
  2. BIOZZI G., STIFFEL C., LEMINOR L., MOUTON D., BOUTHILLIER Y. ETUDE QUANTITATIVE DE L'EFFET OPSONISANT DES IMMUNS'ERUMS SUR LA PHAGOCYTOSE DES SALMONELLA PAR LES CELLULES DU SYST'EME R'ETICULO-ENDOTH'ELIAL IN VIVO. Ann Inst Pasteur (Paris) 1963 Oct;105:635–666. [PubMed] [Google Scholar]
  3. BRAUN W., POMALES-LEBRON A., STINEBRING W. R. Interactions between mononuclear phagocytes and Brucella abortus strains of different virulence. Proc Soc Exp Biol Med. 1958 Feb;97(2):393–397. doi: 10.3181/00379727-97-23752. [DOI] [PubMed] [Google Scholar]
  4. Bascoul S., Cannat A., Huguet M. F., Serre A. Studies on the immune protection to murine experimental brucellosis conferred by Brucella fractions. I. Positive role of immune serum. Immunology. 1978 Aug;35(2):213–221. [PMC free article] [PubMed] [Google Scholar]
  5. Birmingham J. R., Jeska E. L. Characterization of macrophage functions in mice infected with Brucella abortus. Infect Immun. 1981 Jun;32(3):1079–1083. doi: 10.1128/iai.32.3.1079-1083.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Bosseray N., Plommet M. Antagonism between two immunogens extracted from Brucella (cell wall peptidoglycan and lipopolysaccharide fractions) and inactivity of the brucellin allergen in immunization of the mouse. Ann Microbiol (Paris) 1980 Mar-Apr;131A(2):157–169. [PubMed] [Google Scholar]
  7. Bosseray N., Plommet M., De Rycke J. Evolution de l'infection de la souris par Brucella abortus, Brucella melitensis et Brucella suis vers l'état chronique et la guérison. Ann Rech Vet. 1982;13(2):153–161. [PubMed] [Google Scholar]
  8. Bosseray N., Plommet M., Dubray G. Immunogenic activity of a cell wall fraction extracted from Brucella abortus in guinea-pigs. Ann Microbiol (Paris) 1978 Nov-Dec;129 B(4):571–579. [PubMed] [Google Scholar]
  9. Cheers C., Pagram F. Macrophage activation during experimental murine brucellosis: a basis for chronic infection. Infect Immun. 1979 Feb;23(2):197–205. doi: 10.1128/iai.23.2.197-205.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Dubray G., Bézard G. Isolation of three Brucella abortus cell-wall antigens protective in murine experimental brucellosis. Ann Rech Vet. 1980;11(4):367–373. [PubMed] [Google Scholar]
  11. HOLLAND J. J., PICKETT M. J. A cellular basis of immunity in experimental Brucella infection. J Exp Med. 1958 Sep 1;108(3):343–360. doi: 10.1084/jem.108.3.343. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Halliburton B. L., Hinsdill R. D. Recall of acquired cellular resistance in mice by antigens from killed Brucella. Infect Immun. 1972 Jan;5(1):42–47. doi: 10.1128/iai.5.1.42-47.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Hurvell B. Bakgrunden till den serologiska korsreaktionen mellan Yersinia och Brucella samt möjligheter till differentialdiagnostik med ELISA-teknik och raketelektrofores. Nord Vet Med. 1978 Jul-Aug;30(7-8):305–317. [PubMed] [Google Scholar]
  14. Hurvell B., Lindberg A. A. Serological cross-reactions between different Brucella species and Yersinia enterocolitica. Immunochemical studies on phenol-water extracted lipopolysaccharides from Brucella abortus and Yersinia enterocolitica type IX. Acta Pathol Microbiol Scand B Microbiol Immunol. 1973 Feb;81(1):113–119. [PubMed] [Google Scholar]
  15. Jeunet F. S., Cain W., Good R. A. Differential recognition of Brucella organisms by Kupffer cells: studies with isolated perfused liver. Proc Soc Exp Biol Med. 1968 Oct;129(1):187–190. doi: 10.3181/00379727-129-33280. [DOI] [PubMed] [Google Scholar]
  16. Leong D., Diaz R., Milner K., Rudbach J., Wilson J. B. Some structural and biological properties of Brucella endotoxin. Infect Immun. 1970 Feb;1(2):174–182. doi: 10.1128/iai.1.2.174-182.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. MACKANESS G. B. THE IMMUNOLOGICAL BASIS OF ACQUIRED CELLULAR RESISTANCE. J Exp Med. 1964 Jul 1;120:105–120. doi: 10.1084/jem.120.1.105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Madraso E. D., Cheers C. Polyadenylic acid-polyuridylic acid (poly A : U) and experimental murine brucellosis. I. Effect of single and double-stranded polynucleotides on Brucella abortus in vivo and in vitro. Immunology. 1978 Jul;35(1):69–76. [PMC free article] [PubMed] [Google Scholar]
  19. Madraso E. D., Cheers C. Polyadenylic acid-polyuridylic acid (poly A : U) and experimental murine brucellosis. II. Macrophages as target cells of poly A : U in experimental brucellosis. Immunology. 1978 Jul;35(1):77–84. [PMC free article] [PubMed] [Google Scholar]
  20. Moreno E., Berman D. T., Boettcher L. A. Biological activities of Brucella abortus lipopolysaccharides. Infect Immun. 1981 Jan;31(1):362–370. doi: 10.1128/iai.31.1.362-370.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Moreno E., Berman D. T. Brucella abortus lipopolysaccharide is mitogenic for spleen cells of endotoxin-resistant C3H/HeJ mice. J Immunol. 1979 Dec;123(6):2915–2919. [PubMed] [Google Scholar]
  22. POMALES-LEBRON A., STINEBRING W. R. Intracellular multiplication of Brucella abortus in normal and immune mononuclear phagocytes. Proc Soc Exp Biol Med. 1957 Jan;94(1):78–83. doi: 10.3181/00379727-94-22860. [DOI] [PubMed] [Google Scholar]
  23. Pardon P., Marly J. Resistance of Brucella abortus infected mice to intravenous or intraperitoneal Brucella reinfection. Ann Immunol (Paris) 1976 Jan-Feb;127(1):57–70. [PubMed] [Google Scholar]
  24. Pardon P., Marly J. Resistance of normal or immunized guinea pigs against a subcutaneous challenge of Brucella abortus. Ann Rech Vet. 1978;9(3):419–425. [PubMed] [Google Scholar]
  25. Pardon P. Resistance against a subcutaneous Brucella challenge of mice immunized with living or dead Brucella or by transfer of immune serum. Ann Immunol (Paris) 1977 Nov-Dec;128(6):1025–1037. [PubMed] [Google Scholar]
  26. Plommet M., Bosseray N. Le contrôle des vaccins antibrucelliques par dénombrement des Brucella dans la rate de souris, vaccinées ou non, inoculées par voie intrapéritonéale. J Biol Stand. 1977;5(4):261–274. doi: 10.1016/s0092-1157(77)80011-5. [DOI] [PubMed] [Google Scholar]
  27. Plommet M., Plommet A. M. Evolution de l'infection splénique de souris de quatre lignées, inoculées par voie veineuse, par trois doses de Brucella abortus. Ann Rech Vet. 1982;12(4):345–351. [PubMed] [Google Scholar]
  28. Ralston D. J., Elberg S. S. Serum-mediated immune cellular responses to Brucella melitensis REV 1. II. Restriction of Brucella by immune sera and macrophages. J Reticuloendothel Soc. 1969 Apr;6(2):109–139. [PubMed] [Google Scholar]
  29. Ralston D. J., Elberg S. S. Serum-mediated immune cellular responses to Brucella melitensis. 7. The separation and assay of serum globulins responsible for macrophage stimulation and Brucella inhibition. J Infect Dis. 1971 May;123(5):507–518. doi: 10.1093/infdis/123.5.507. [DOI] [PubMed] [Google Scholar]
  30. Ralston D. J., Elberg S. S. Serum-mediated immune cellular responses to Brucella melitensis. I. Role of a macrophage-stimulating factor in promoting ingestion of Brucella by streptomycin-protected cells. J Bacteriol. 1968 Jul;96(1):24–38. doi: 10.1128/jb.96.1.24-38.1968. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Ralston D. J., Elberg S. S. Serum-mediated immune cellular responses to Brucella melitensis. VI. The sequence of cellular and serologic changes after immunization of the rabbit with the Rev I vaccine strain. J Infect Dis. 1971 Jun;123(6):595–602. doi: 10.1093/infdis/123.6.595. [DOI] [PubMed] [Google Scholar]
  32. Ralston D. J., Elberg S. S. The cell wall as the antigenic site for antibodies stimulating ingestion (MSF) and inhibition (BIF) of Brucella in macrophages from normal and immune animals. Br J Exp Pathol. 1971 Apr;52(2):130–137. [PMC free article] [PubMed] [Google Scholar]
  33. Riglar C., Cheers C. Macrophage activation during experimental murine brucellosis. II. Inhibition of in vitro lymphocyte proliferation by brucella-activated macrophages. Cell Immunol. 1980 Jan;49(1):154–167. doi: 10.1016/0008-8749(80)90065-9. [DOI] [PubMed] [Google Scholar]
  34. SULITZEANU D. Passive protection experiments with Brucella antisera. J Hyg (Lond) 1955 Jun;53(2):133–142. doi: 10.1017/s0022172400000619. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. SULITZEANU D. The fate of killed, radioiodinated Brucella abortus injected into mice. J Immunol. 1959 Apr;82(4):304–312. [PubMed] [Google Scholar]
  36. Vendrell J. P., Escande A., Cannat A., Huguet M. F., Serre A. Mitogenic activity of two Brucella fractions for murine B lymphocytes. Immunology. 1980 May;40(1):41–46. [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES